MX2010001742A - Nuevos derivados de piperazina-amida. - Google Patents
Nuevos derivados de piperazina-amida.Info
- Publication number
- MX2010001742A MX2010001742A MX2010001742A MX2010001742A MX2010001742A MX 2010001742 A MX2010001742 A MX 2010001742A MX 2010001742 A MX2010001742 A MX 2010001742A MX 2010001742 A MX2010001742 A MX 2010001742A MX 2010001742 A MX2010001742 A MX 2010001742A
- Authority
- MX
- Mexico
- Prior art keywords
- amide derivatives
- piperazine amide
- novel piperazine
- novel
- lxr
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
La invención se refiere a nuevos derivados de piperazina-amida de la fórmula (l) en la que de R1 a R11, W, X e Y tienen los significados definidos en la descripción y en las reivindicaciones, así como a sus sales fisiológicamente aceptables. Estos compuestos se fijan sobre el LXR alfa y LXR beta y pueden utilizarse como medicamentos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07114219 | 2007-08-13 | ||
PCT/EP2008/060213 WO2009021868A2 (en) | 2007-08-13 | 2008-08-04 | Novel piperazine amide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010001742A true MX2010001742A (es) | 2010-03-10 |
Family
ID=40298643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010001742A MX2010001742A (es) | 2007-08-13 | 2008-08-04 | Nuevos derivados de piperazina-amida. |
Country Status (17)
Country | Link |
---|---|
US (1) | US8288541B2 (es) |
EP (1) | EP2188266B1 (es) |
JP (1) | JP5220858B2 (es) |
KR (1) | KR101171507B1 (es) |
CN (2) | CN101778831B (es) |
AR (1) | AR067904A1 (es) |
AU (1) | AU2008288537B2 (es) |
BR (1) | BRPI0815479A2 (es) |
CA (1) | CA2695088C (es) |
CL (1) | CL2008002356A1 (es) |
ES (1) | ES2393822T3 (es) |
MX (1) | MX2010001742A (es) |
PE (1) | PE20090592A1 (es) |
RU (1) | RU2454412C2 (es) |
TW (1) | TWI364420B (es) |
WO (1) | WO2009021868A2 (es) |
ZA (1) | ZA201001061B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130274212A1 (en) | 2010-09-07 | 2013-10-17 | Snu R&Db Foundation | Sesterterpene Compounds and Use Thereof |
CN103172635B (zh) * | 2011-12-21 | 2016-04-27 | 上海医药工业研究院 | 哌嗪或哌啶类化合物、其盐、中间体、制备方法及应用 |
EP3441390A1 (en) | 2012-03-02 | 2019-02-13 | Ralexar Therapeutics, Inc. | Liver x receptor (lxr) modulators for the treatment of dermal diseases, disorders and conditions |
ES2765573T3 (es) | 2012-08-13 | 2020-06-09 | Univ Rockefeller | Tratamiento y diagnóstico de melanoma |
CA2923175C (en) | 2013-09-04 | 2022-07-26 | Alexar Therapeutics, Inc. | Liver x receptor (lxr) modulators |
KR20160048997A (ko) | 2013-09-04 | 2016-05-04 | 알렉사르 테라퓨틱스 인코퍼레이티드 | 간 x 수용체 (lxr) 조절인자 |
EP3091970B1 (en) | 2014-01-10 | 2020-10-28 | Rgenix, Inc. | Lxr agonists and uses thereof |
EP3402477A4 (en) | 2016-01-11 | 2019-08-21 | The Rockefeller University | METHODS FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH SUPPRESSIVE CELLS DERIVED FROM MYELOID CELLS |
DK3515895T3 (da) | 2016-09-21 | 2021-10-18 | Vectus Biosystems Ltd | Imidazolderivater til behandling af hypertension og/eller fibrose |
CA3078981A1 (en) | 2017-11-21 | 2019-05-31 | Rgenix, Inc. | Polymorphs and uses thereof |
WO2021119397A1 (en) | 2019-12-13 | 2021-06-17 | Rgenix, Inc. | Metal salts and uses thereof |
KR20220152159A (ko) * | 2021-05-07 | 2022-11-15 | 엠비디 주식회사 | 신규한 헤테로사이클 화합물 및 이의 용도 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US530238A (en) * | 1894-12-04 | Guard for lathes | ||
DK350383A (da) | 1982-08-27 | 1984-02-28 | Hoffmann La Roche | Phosphorforbindelser |
DE59009670D1 (de) | 1989-05-18 | 1995-10-26 | Hoffmann La Roche | Phosphorverbindungen. |
EP0530335B1 (de) | 1991-03-15 | 1996-08-14 | F. Hoffmann-La Roche Ag | Diphosphonsaurederivate als zwischenprodukte zur herstellung von diphosphinliganden |
US5256321A (en) | 1992-07-10 | 1993-10-26 | The Lubrizol Corporation | Grease compositions |
IL115420A0 (en) * | 1994-09-26 | 1995-12-31 | Zeneca Ltd | Aminoheterocyclic derivatives |
CN1164232A (zh) * | 1994-09-26 | 1997-11-05 | 曾尼卡有限公司 | 作为抗血栓形成剂或抗凝血剂的氨基杂环衍生物 |
IL128428A0 (en) * | 1996-08-14 | 2000-01-31 | Zeneca Ltd | Substituted pyrimidine derivatives and their pharmaceutical use |
US6900244B2 (en) | 2002-05-24 | 2005-05-31 | Pharmacia Corporation | Anilino liver X-receptor modulators |
WO2004002965A1 (de) * | 2002-06-29 | 2004-01-08 | Zentaris Gmbh | Aryl- und heteroarylcarbonylpiperazine und deren verwendung zur behandlung gutartiger und bösartiger tumorerkrankungen |
WO2004076418A1 (en) | 2003-02-28 | 2004-09-10 | Galderma Research & Development, S.N.C. | Ligands that modulate lxr-type receptors |
FR2869904B1 (fr) * | 2004-05-07 | 2006-07-28 | Fournier S A Sa Lab | Modulateurs des recepteurs lxr |
MXPA06014573A (es) * | 2004-06-24 | 2007-03-12 | Incyte Corp | Compuestos amido y su uso como farmaceuticos. |
DE102005000666B3 (de) * | 2005-01-04 | 2006-10-05 | Sanofi-Aventis Deutschland Gmbh | Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
MX2009010567A (es) | 2007-03-30 | 2009-10-22 | Hoffmann La Roche | Derivados de imidazolidinona. |
-
2008
- 2008-08-04 WO PCT/EP2008/060213 patent/WO2009021868A2/en active Application Filing
- 2008-08-04 BR BRPI0815479-1A2A patent/BRPI0815479A2/pt not_active IP Right Cessation
- 2008-08-04 JP JP2010520529A patent/JP5220858B2/ja not_active Expired - Fee Related
- 2008-08-04 CN CN200880103083.XA patent/CN101778831B/zh not_active Expired - Fee Related
- 2008-08-04 CA CA2695088A patent/CA2695088C/en not_active Expired - Fee Related
- 2008-08-04 ES ES08786826T patent/ES2393822T3/es active Active
- 2008-08-04 KR KR1020107005485A patent/KR101171507B1/ko not_active IP Right Cessation
- 2008-08-04 EP EP08786826A patent/EP2188266B1/en not_active Not-in-force
- 2008-08-04 MX MX2010001742A patent/MX2010001742A/es active IP Right Grant
- 2008-08-04 AU AU2008288537A patent/AU2008288537B2/en not_active Ceased
- 2008-08-04 CN CN201410037876.3A patent/CN103772299A/zh active Pending
- 2008-08-04 RU RU2010108943/04A patent/RU2454412C2/ru not_active IP Right Cessation
- 2008-08-06 US US12/186,555 patent/US8288541B2/en not_active Expired - Fee Related
- 2008-08-11 CL CL2008002356A patent/CL2008002356A1/es unknown
- 2008-08-11 AR ARP080103496A patent/AR067904A1/es not_active Application Discontinuation
- 2008-08-11 PE PE2008001361A patent/PE20090592A1/es not_active Application Discontinuation
- 2008-08-12 TW TW097130742A patent/TWI364420B/zh active
-
2010
- 2010-02-12 ZA ZA2010/01061A patent/ZA201001061B/en unknown
Also Published As
Publication number | Publication date |
---|---|
TWI364420B (en) | 2012-05-21 |
EP2188266A2 (en) | 2010-05-26 |
US20090048264A1 (en) | 2009-02-19 |
BRPI0815479A2 (pt) | 2015-02-10 |
KR20100043096A (ko) | 2010-04-27 |
ES2393822T3 (es) | 2012-12-28 |
RU2454412C2 (ru) | 2012-06-27 |
CA2695088C (en) | 2013-03-12 |
RU2010108943A (ru) | 2011-09-20 |
WO2009021868A3 (en) | 2009-04-09 |
JP5220858B2 (ja) | 2013-06-26 |
CN103772299A (zh) | 2014-05-07 |
US8288541B2 (en) | 2012-10-16 |
AR067904A1 (es) | 2009-10-28 |
AU2008288537B2 (en) | 2011-03-24 |
TW200916463A (en) | 2009-04-16 |
ZA201001061B (en) | 2010-11-24 |
CN101778831A (zh) | 2010-07-14 |
CL2008002356A1 (es) | 2009-05-29 |
EP2188266B1 (en) | 2012-10-17 |
WO2009021868A2 (en) | 2009-02-19 |
AU2008288537A1 (en) | 2009-02-19 |
KR101171507B1 (ko) | 2012-08-07 |
JP2010535834A (ja) | 2010-11-25 |
CN101778831B (zh) | 2014-08-20 |
CA2695088A1 (en) | 2009-02-19 |
PE20090592A1 (es) | 2009-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010001742A (es) | Nuevos derivados de piperazina-amida. | |
MX2009010567A (es) | Derivados de imidazolidinona. | |
MX2010003224A (es) | Derivados de biaril sulfonamida. | |
MX2009010218A (es) | Derivados de aza-piridopirimidinona. | |
TW200616940A (en) | Novel hexafluoroisopropanol substituted ether derivatives | |
MX2010002341A (es) | Derivados de bencimidazol usados como agonistas del receptor x de farnesoide. | |
TW200745032A (en) | Novel heterobicyclic derivatives | |
MX2009004441A (es) | Derivados de indazol utiles como inhibidores de las isoformas de higado. | |
TW200833324A (en) | Sulfonamide derivatives | |
GEP20125487B (en) | Organic compounds and their use | |
TW200626527A (en) | Novel hexafluoroisopropanol derivatives | |
MX2010006565A (es) | Derivados de benzimidazol sustituido por carboxilo o hidroxilo. | |
MY153921A (en) | Aminopyrazole derivatives | |
MX2012007536A (es) | Derivados de heteroarilo que contienen nitrogeno. | |
DK2074120T3 (da) | Tropan-forbindelser | |
TW200720270A (en) | Novel cyclic amines | |
IN2012DN03337A (es) | ||
MX2009011578A (es) | 6-fenilpirimidinonas como moduladores de pim. | |
MX2010005824A (es) | Derivados de aminotiazol. | |
TW200633963A (en) | Novel cyclohexane derivatives | |
MX2011008360A (es) | Derivados de piridazinona sustituida con heteroarilo. | |
UA109037C2 (uk) | Триазолопіридини | |
GEP201606545B (en) | 2-piperazin-1-yl-4h-1,3-benzo-thiazin-4-one derivatives and their use for treatment of mammalian infections | |
JO2682B1 (en) | Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof | |
IN2012DN01232A (es) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |